Leadership


Pioneering innovation with solid, experienced leadership




The ability to serve the cardiovascular market with state-of-the-art medical technology begins with solid, experienced leadership. Our Board of Directors and Executive Leadership are dedicated to collaborating with physicians to help get their patients back to what matters.

Executive Leadership Team

Scott Ward

Scott R. Ward

President & CEO

Mr. Ward has been a member of our Board of Directors since 2013 and has served as Chairman since November 2014. Mr. Ward served as our Interim President and Chief Executive Officer commencing in November 2015. In August 2016, Mr. Ward was appointed President and Chief Executive Officer.

Read More

Since 2013, Mr. Ward has been one of the Managing Directors at SightLine Partners. Following his appointment as our President and Chief Executive Officer, Mr. Ward continues to be a Managing Director of Sightline Opportunity Management Fund II, LLC, and may provide limited advisory and consulting services to Sightline Partners in this capacity.

From 1981 to 2010, Mr. Ward was employed by Medtronic, Inc., and held a number of senior leadership positions. Mr. Ward was Senior Vice President and President of Medtronic’s CardioVascular business from May 2007 to November 2010. Prior to that he was Senior Vice President and President of Medtronic’s Vascular business from May 2004 to May 2007, Senior Vice President and President of Medtronic’s Neurological and Diabetes business, from February 2002 to May 2004, and was President of Medtronic’s Neurological business from January 2000 to January 2002. He was Vice President and General Manager of Medtronic’s Drug Delivery business from 1995 to 2000. Prior to that, Mr. Ward led Medtronic’s Neurological Ventures in the successful development of new therapies. Mr. Ward serves on the boards of several private companies. Until April 4, 2016, Mr. Ward was the Chairman of the Board of Creganna Medical. Mr. Ward served as a member of the Board of Surmodics, Inc., from September 2010 to March 2015.

Larry Betterley

Laurence L. Betterley

Vice President of Administration

Mr. Betterley joined CSI in April 2008 as Chief Financial Officer (CFO). In February 2018, he was named Vice President of Administration. Previously, Mr. Betterley was CFO at Cima NanoTech, Inc., from May 2007 to April 2008; Senior Vice President and CFO of PLATO Learning, Inc., from June 2004 to January 2007; Senior Vice President and CFO of Diametrics Medical, Inc., from 1996 to 2003; and CFO of Cray Research Inc. from 1994 to 1996.

Ryan

Ryan D. Egeland, MD PhD

Vice President, Medical Affairs

Dr. Egeland joined CSI as Vice President of Medical Affairs in November of 2017. He has responsibilities providing global leadership, medical counsel and guidance to the organization on matters related to cardiovascular medicine, product and technology development, medical education, market development, quality assurance, clinical program design, clinical data analysis, regulatory affairs, and business development. Prior to joining CSI, Dr. Egeland held roles in marketing, medical affairs, and business development at Medtronic. Before this, he trained as a plastic and reconstructive surgeon at Northwestern Memorial Hospital, and received an MD with honors from Harvard Medical School. Dr. Egeland also holds a PhD in biochemistry and engineering from the University of Oxford, where he also completed a MBA as a Rhodes Scholar.

Laura Gillund

Laura J. Gillund

Chief Talent Officer

Ms. Gillund, Chief Talent Officer, joined CSI in September 2013. From August 2002 to May 2012, Laura was Vice President of Human Resources for C.H. Robinson Worldwide, Inc. From 1995 to 2002, Ms. Gillund was employed at Wells Fargo Home Mortgage, most recently as Senior Vice President Human Resources. Ms. Gillund serves as a member of the Board of Directors for Allina Health System.

John Hastings

John M. Hastings

Vice President, Manufacturing and Operations

Mr. Hastings joined CSI as Vice President of Manufacturing and Operations in October of 2017. He is responsible for global Manufacturing, Operations, Supply Chain and Distribution. Prior to joining CSI, Mr. Hastings held several leadership roles at Abbott Laboratories (formerly St. Jude Medical), most recently as Sr. Site Director, Operations. Mr. Hastings served as Director of Engineering for American Medical Systems prior to his role with Abbott.

Jeffery Points

Jeffrey S. Points

Chief Financial Officer

Mr. Points joined CSI in September 2007 as Corporate Controller, became Senior Director and Controller in July 2013, Corporate Controller and Treasurer in January 2015, Vice President, Corporate Controller and Treasurer in May 2017 and was promoted to Chief Financial Officer in February 2018. From July 2005 to September 2007, Mr. Points was Assistant Controller at Empi, a manufacturer and provider of non-invasive medical products for pain management and physical rehabilitation. From January 1998 to July 2005, Mr. Points held various leadership positions at CliftonLarsonAllen, a national public accounting firm. Mr. Points also serves as a member of the Board of Directors for The Phoenix Residence, Inc.

Rhonda Rob

Rhonda J. Robb

Chief Operating Officer

Ms. Robb joined CSI as Chief Operating Officer in January 2018. Ms. Robb brings more than 30 years of medical device leadership to the company. Prior to CSI, she held several positions at Medtronic, most recently as Vice President and General Manager of the Heart Valve Therapies Business, including the transcatheter aortic valve business. In previous roles, Ms. Robb held leadership positions in Medtronic’s Coronary, Peripheral, and Cardiac Rhythm and Heart Failure businesses.

Alex Rosenstein

Alexander Rosenstein

General Counsel & Corporate Secretary

Mr. Rosenstein joined CSI in September 2014 as Corporate Legal and Compliance Counsel, became Corporate Secretary in November 2014, and was promoted to General Counsel in March 2015. From October 2005 to September 2014, Mr. Rosenstein was an attorney at Fredrikson & Byron, P.A., in Minneapolis. From 1998 to September 2005, he was an attorney practicing in New York City.

Sandra Sedo

Sandra M. Sedo

Chief Compliance Officer

Ms. Sedo joined CSI in June 2016. As Chief Compliance Officer, she is responsible for managing the company’s ethics and compliance program, including implementation of a Corporate Integrity Agreement. Ms. Sedo has over 25 years of experience as a lawyer and compliance professional, including being a partner at Dorsey & Whitney, LLP and as an in-house attorney and Deputy Compliance Officer at Medtronic. Ms. Sedo has worked exclusively in the medical device industry since 2005.

David Whitescarver

David S. Whitescarver

Vice President, Corporate Development & Intellectual Property

Mr. Whitescarver joined CSI as Vice President of Corporate Development and Intellectual Property in June 2017. Mr. Whitescarver brings more than 15 years of global leadership experience in the biomedical sector to the company, including senior leadership positions at Medtronic. Prior to this experience, Mr. Whitescarver led global teams at a Fortune 500 technology company and practiced law with a leading Wall Street firm.

Board of Directors

Scott Ward

Scott R. Ward

President & CEO

Mr. Ward has been a member of our Board of Directors since 2013 and has served as Chairman since November 2014.

Read More

Mr. Ward served as our Interim President and Chief Executive Officer commencing in November 2015. In August 2016, Mr. Ward was appointed President and Chief Executive Officer.

Since 2013, Mr. Ward has been one of the Managing Directors at SightLine Partners. Following his appointment as our President and Chief Executive Officer, Mr. Ward continues to be a Managing Director of Sightline Opportunity Management Fund II, LLC, and may provide limited advisory and consulting services to Sightline Partners in this capacity.

From 1981 to 2010, Mr. Ward was employed by Medtronic, Inc., and held a number of senior leadership positions. Mr. Ward was Senior Vice President and President of Medtronic’s CardioVascular business from May 2007 to November 2010. Prior to that he was Senior Vice President and President of Medtronic’s Vascular business from May 2004 to May 2007, Senior Vice President and President of Medtronic’s Neurological and Diabetes business, from February 2002 to May 2004, and was President of Medtronic’s Neurological business from January 2000 to January 2002. He was Vice President and General Manager of Medtronic’s Drug Delivery business from 1995 to 2000. Prior to that, Mr. Ward led Medtronic’s Neurological Ventures in the successful development of new therapies. Mr. Ward serves on the boards of several private companies. Until April 4, 2016, Mr. Ward was the Chairman of the Board of Creganna Medical. Mr. Ward served as a member of the Board of Surmodics, Inc., from September 2010 to March 2015.

Martha Aronson

Martha G. Aronson

Director

Ms. Aronson has been a member of CSI’s Board of Directors since February 2017.

Read More

From 2012 to 2016, Ms. Aronson served as the Executive Vice President and President of Global Healthcare at Ecolab, Inc. From 2010 to 2012, she was Senior Vice President and President, North America, at Hill-Rom Holdings, Inc. Prior to that, Aronson worked at Medtronic, Inc., in various general management roles, both in the U.S. and internationally, for 18 years. She served on the executive committee as Senior Vice President and Chief Talent Officer. She currently serves as a Director on the boards of Conmed Corporation and Methode Electronics, and she served as a Director of Hutchinson Technology, Inc., from 2010 to 2016.

Scott Bartos

Scott Bartos

Director

Mr. Bartos has been a member of CSI’s Board of Directors since October 2012.

Read More

Mr. Bartos has more than 25 years of experience as a healthcare executive and Director. He previously served as Chairman & Chief Executive Officer for Rural/Metro Corporation, the nation’s leading provider of ambulance, fire protection and safety services, until the company was sold in 2015. Prior to that, Mr. Bartos was President, Chief Executive Officer, and Director of LaVie Care Centers, a national long-term care company with revenues exceeding $1.0 billion annually, from July 2009 through the sale of the company in December 2011. From December 2008 to July 2009, he was an Executive in Residence at Warburg Pincus, LLC. Mr. Bartos was Division President for Gambro Healthcare, Inc., from 2000 to 2004 and COO–East from 2004 to 2005. Mr. Bartos previously was the founder, President, CEO and a Director of Endoscopy Specialists Inc. Mr. Bartos is currently a Director for Alliance HealthCare Services, Inc., and Outset Medical.

Brent Blackey

Brent G. Blackey

Director

Mr. Blackey served as the President and Chief Operating Officer for Holiday Companies from December 2004 until December 2017, when it was sold to Alimentation Couche-Tard.

Read More

Between 2002 and 2004, Mr. Blackey was a Senior Partner at the accounting firm of Ernst & Young, LLP. Prior to 2002, Mr. Blackey served most recently as a Senior Partner at the accounting firm of Arthur Andersen, LLP. Mr. Blackey serves on the Board of Directors of Coborn’s Inc. since January 2018 and the Advisory Boards of Northern Tool and Equipment Company, Inc. and Oppidan, Inc. both since December 2017. Mr. Blackey had served on the Board of Directors of Datalink Corporation, a publicly-held company, from April 2006 until it was sold in January 2017. Mr. Blackey also serves on the Board of Overseers for the University of Minnesota’s Carlson School of Management.

Ned Brown

Edward Brown

Director

Mr. Brown has been a member of CSI’s Board of Directors since February 2009.

Read More

Mr. Brown was a member of Replidyne’s Board of Directors from May 2007 to February 2009. Mr. Brown currently serves as a Partner at Health Evolution Partners. Mr. Brown was previously a Managing Director at TPG Growth from 2007 to 2009, and a Managing Director and co-founder of Healthcare Investment Partners, a private equity fund focused on healthcare investments, from 2004 to 2007. Before Healthcare Investment Partners, Mr. Brown was a Managing Director in the healthcare group of Credit Suisse Group where he led the firm’s West Coast healthcare effort and was one of the senior partners responsible for the firm’s global life sciences practice. Mr. Brown currently serves on the board of two private companies, Freedom Innovations, LLC, and Prolacta Biosciences, Inc. Mr. Brown previously served on the public company boards of Angiotech Pharmaceuticals, Inc., from January 2007 to June 2011, Oculus Innovative Sciences, Inc., from September 2005 to June 2008, and Replidyne, Inc., from May 2007 to February 2009, as well as several private company boards.

Billy Cohn

William Cohn, M.D.

Director

Dr. Cohn has been a member of CSI’s Board of Directors since February 2015.

Read More

Dr. Cohn is a Cardiothoracic Surgeon, the Director of Technology and Innovation at the Texas Heart Institute, and the Director of the Department of Surgery Incubator at Baylor College of Medicine, where he is also professor of surgery. In addition, he is an adjunct professor of bioengineering at both Rice University and the University of Houston. He is a venture partner with Santé Ventures, an early stage life science fund in Austin, Texas. Dr. Cohn has more than 90 U.S. patents granted or pending for medical device development.

Gus Lawlor

Augustine Lawlor

Director

Mr. Lawlor has been a member of CSI’s Board of Directors since February 2009.

Read More

He was a member of Replidyne’s Board of Directors from March 2002 to February 2009. Mr. Lawlor is the Managing Partner of HealthCare Ventures, LLC, where he was a Managing Director from 2000 to 2007. Mr. Lawlor was previously Chief Operating Officer of LeukoSite, Inc., and has also served as a management consultant with KPMG Peat Marwick. Mr. Lawlor serves on the Board of Directors of numerous companies, and he served on the Board of Directors of Human Genome Sciences, Inc., from March 2004 to August 2012 and the Board of Directors of Replidyne, Inc., from March 2002 to March 2009.